The therapy priced at nearly two-thirds the cost of the currently available products in the market Developed in-house, the drug offers bio-availa...
Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DR REDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today...
Glenmark has successfully developed the API and the formulations for the product through its in-house R&D team Mumbai, India; Glenmark Pharmace...
Sanofi to provide Plaquenil® (hydroxychloroquine) wherever possible while securing appropriate supply levels for currently approved indications; T...
• Companies to negotiate a collaboration on the development of a breakthrough COVID-19 self-test solution based on Luminostics’ proprietary techno...
March 23, 2020: Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted tentative approval by the United States Food & Drug Administration ...
As part of the agreement, Glenmark’s VWash brand will be transferred to Hindustan Unilever Limited (‘HUL’) Glenmark Pharmaceuticals Ltd, a ...
The 112 year old Alembic Group, based in Vadodara has stepped up its humanitarian effort and announced an allocation of Rs. 10 crore towards the COVID...
Mumbai, India, March 27, 2020 – Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUN PHARMA, BSE: 524715, “Sun Pharma...
Tuesday, April 14, 2020 As the COVID-19 pandemic continues to impact the world around us, Dr. Reddy’s is addressing this unprecedented challenge ...
Piramal Foundation, the group's philanthropic arm that has a presence in 25 states across India continues to work in partnership with the government, ...
Hyderabad, India, April 13, 2020 — Dr. Reddy’s Laboratories Ltd., today announced the launch of Invista®, a formulation of Dasatinib that is bioe...
